Atopic dermatitis; to use or not to use the corticosteroids; mother's dilemma! A case report by unknown
POSTER PRESENTATION Open Access
Atopic dermatitis; to use or not to use the
corticosteroids; mother’s dilemma! A case report
Erjola Piluri Ziu1*, Eris Mesonjesi2, Irena Savo3, Blerina Bregu2, Maria Zoto2
From EAACI Skin Allergy Meeting 2014
Krakow, Poland. 18-20 September 2014
Background
Atopic dermatitis (AD) is a chronic, inflammatory skin
disorder of the childhood. The patient with AD is affected
by the social stigma of a visible skin condition. Topical
corticosteroids being the first-line pharmacologic treat-
ments can effectively control atopic flares in the majority
of patients.
Methods
We describe a case of severe AD untreated cause of
mother’s corticosteroid phobia.
Case report
A 10-years-old female patient was presented with a poorly
controlled AD. Widespread erythemas, lichenified plaques,
were present on the face, neck, trunk and extremities.
Numerous excoriations were seen. The patient complained
of an unbearable pruritus. The patient had a history of
mild AD since early infancy, managed by emollients. Aller-
gic rhinitis was diagnosed at the age of 8. The patient had
no family history for atopy. The last year the patient
experienced an aggravation of her condition as presented.
The little girl for one whole year was living with her pruri-
tus, with the stigma and the numerous nick names sets by
the other children. Our patient did not use topical steroids
due to the girl’s mother concerns about the corticosteroids
side effects, despite the numerous prescriptions of allergist
and dermatologists. SCORAD at first visit was 93.8.
Laboratory tests showed levels of specific IgE for D. ptero-
nyssinus, Timothy grass pollen and P judaica >100 kU/ml.
She was not sensitized to food allergens. We did not per-
form skin tests cause of the severity of her AD. We made
four consecutive appointments, in order to explain to the
mother the nature of AD, the treatment needed, the side
effects of the topical steroids, but we did not achieved
results. She declare, that she is going to visit her child out-
side the country, where no one is going to prescribe to her
little girl topical corticosteroids.
Conclusion
AD is a chronic, inflammatory, itchy, episodic, skin condi-
tion that develops in early childhood in the majority of
cases. Severe AD has the tendency to follow a persistent
course and can be associated with a lack of self-confidence
that can impair social development. Topical corticoster-
oids are gold standard for atopic dermatitis. The “corticos-
teroid phobia” is a phenomenon mentioned often in the
literature. It is an irrational fear and anxiety of patients
about using topical corticosteroid preparations. One of the
most important sources of information about corticoster-
oids must be the doctor’s consultation.
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